Medical and Pharmaceutical Benefits MIT70:
New Painkiller DevelopmentMitragynine has the potential to be developed into a novel analgesic that mimics some opioid effects but with potentially lower addiction risk—useful for cancer or chronic pain patients.
Opioid Withdrawal TreatmentStudies suggest that mitragynine may alleviate withdrawal symptoms in opioid-dependent individuals, making it a candidate for addiction treatment support.
Standardized Pharmaceutical FormulationsHigh-purity extracts can be used in clinical trials and further developed into controlled, measurable doses for modern pharmaceutical use.
70% Mitragynine Extract Freebase
$3,500.00Price

